Evidence map›Paper›PMID 35576569›Full record

ArticleJMIR formative research2022

Contrasting a Mobile App With a Conversational Chatbot for Reducing Alcohol Consumption: Randomized Controlled Pilot Trial.

Patrick Dulin, Robyn Mertz, Alexandra Edwards, Diane King

Registry-linked trialAbstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04447794 (Can a Chatbot-delivered Alcohol Intervention Engage Users and Enhance Outcomes Over a Smartphone App? Development and Feasibility Testing of a StepAway 'Bot'), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04447794 nacompletednot on this map

Can a Chatbot-delivered Alcohol Intervention Engage Users and Enhance Outcomes Over a Smartphone App? Development and Feasibility Testing of a StepAway 'Bot'

TypeinterventionalSponsorUniversity of Alaska AnchorageRan2020 to 2021Enrolled191ConditionsAlcohol Consumption, Alcohol Use DisorderArmsStep Away Chatbot, Step Away App
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patrick Dulin *Department of Psychology, University of Alaska Anchorage, Anchorage, AK, United States.ORCID https://orcid.org/0000-0003-2134-6513
Robyn Mertz *Department of Psychology, University of Alaska Anchorage, Anchorage, AK, United States.ORCID https://orcid.org/0000-0003-3265-0748
Alexandra EdwardsCenter for Behavior Research and Services, University of Alaska Anchorage, Anchorage, AK, United States.ORCID https://orcid.org/0000-0003-0048-6189
Diane King *Center for Behavior Research and Services, University of Alaska Anchorage, Anchorage, AK, United States.ORCID https://orcid.org/0000-0002-2778-8761

Funding

Can a Chatbot-delivered Alcohol Intervention Engage Users and Enhance Outcomes Over a Smartphone App? Development and Feasibility Testing of a StepAway 'Bot'R34AA026440 · NIAAA · UNIVERSITY OF ALASKA ANCHORAGE · PI DULIN, PATRICK L · 2018 to 2020
$651k
NIAAA NIH HHS R34 AA026440
6 · The paper itself

Abstract

backgroundMobile apps have shown considerable promise for reducing alcohol consumption among problem drinkers, but like many mobile health apps, they frequently report low utilization, which is an important limitation, as research suggests that effectiveness is related to higher utilization. Interactive chatbots have the ability to provide a conversational interface with users and may be more engaging and result in higher utilization and effectiveness, but there is limited research into this possibility.

objectiveThis study aimed to develop a chatbot alcohol intervention based on an empirically supported app (Step Away) for reducing drinking and to conduct a pilot trial of the 2 interventions. Included participants met the criteria for hazardous drinking and were interested in reducing alcohol consumption. The study assessed utilization patterns and alcohol outcomes across the 2 technology conditions, and a waitlist control group.

methodsParticipants were recruited using Facebook advertisements. Those who met the criteria for hazardous consumption and expressed an interest in changing their drinking habits were randomly assigned to three conditions: the Step Away app, Step Away chatbot, and waitlist control condition. Participants were assessed on the web using the Alcohol Use Disorders Identification Test, Adapted for Use in the United States, Readiness to Change Questionnaire, Short Inventory of Problems-Revised, and Timeline Followback at baseline and at 12 weeks follow-up.

resultsA total of 150 participants who completed the baseline and follow-up assessments were included in the final analysis. ANOVA results indicated that participants in the 3 conditions changed their drinking from baseline to follow-up, with large effect sizes noted (ie, η

conclusionsResults indicated that all groups in this study reduced their drinking considerably from baseline to the 12-week follow-up, but no differences were found in the alcohol outcome variables between the groups, possibly because of a combination of small sample size and methodological issues. The app group reported greater use and slightly higher usability scores than the bot group, but the bot group demonstrated improved readiness to change scores over the app group. The strengths and limitations of the app and bot interventions as well as directions for future research are discussed.

trial registrationClinicalTrials.gov NCT04447794; https://clinicaltrials.gov/ct2/show/NCT04447794.

Indexed as

alcoholbrief interventionchatboteffectivenesshazardous drinkingmobile phonesmartphone apputilization

Identifiers

PMID35576569
PMCPMC9152724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.